These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1023 related items for PubMed ID: 27879252

  • 21. Vehicle-dependent Effects of Sphingosine 1-phosphate on Plasminogen Activator Inhibitor-1 Expression.
    Takahashi C, Kurano M, Nishikawa M, Kano K, Dohi T, Miyauchi K, Daida H, Shimizu T, Aoki J, Yatomi Y.
    J Atheroscler Thromb; 2017 Sep 01; 24(9):954-969. PubMed ID: 28321011
    [Abstract] [Full Text] [Related]

  • 22. Lipopolysaccharide and sphingosine-1-phosphate cooperate to induce inflammatory molecules and leukocyte adhesion in endothelial cells.
    Fernández-Pisonero I, Dueñas AI, Barreiro O, Montero O, Sánchez-Madrid F, García-Rodríguez C.
    J Immunol; 2012 Dec 01; 189(11):5402-10. PubMed ID: 23089395
    [Abstract] [Full Text] [Related]

  • 23. [The role of apolipoprotein M and sphingosine 1-phosphate axis in the prevention of atherosclerosis].
    Nádró B, Juhász L, Szentpéteri A, Páll D, Paragh G, Harangi M.
    Orv Hetil; 2018 Feb 01; 159(5):168-175. PubMed ID: 29376427
    [Abstract] [Full Text] [Related]

  • 24. Identification of ApoA4 as a sphingosine 1-phosphate chaperone in ApoM- and albumin-deficient mice.
    Obinata H, Kuo A, Wada Y, Swendeman S, Liu CH, Blaho VA, Nagumo R, Satoh K, Izumi T, Hla T.
    J Lipid Res; 2019 Nov 01; 60(11):1912-1921. PubMed ID: 31462513
    [Abstract] [Full Text] [Related]

  • 25. Apolipoprotein M: bridging HDL and endothelial function.
    Christoffersen C, Nielsen LB.
    Curr Opin Lipidol; 2013 Aug 01; 24(4):295-300. PubMed ID: 23652568
    [Abstract] [Full Text] [Related]

  • 26. Sphingosine 1-phosphate (S1P) carrier-dependent regulation of endothelial barrier: high density lipoprotein (HDL)-S1P prolongs endothelial barrier enhancement as compared with albumin-S1P via effects on levels, trafficking, and signaling of S1P1.
    Wilkerson BA, Grass GD, Wing SB, Argraves WS, Argraves KM.
    J Biol Chem; 2012 Dec 28; 287(53):44645-53. PubMed ID: 23135269
    [Abstract] [Full Text] [Related]

  • 27. Sphingosine-1-phosphate: metabolism, transport, atheroprotection and effect of statin treatment.
    Therond P, Chapman MJ.
    Curr Opin Lipidol; 2022 Jun 01; 33(3):199-207. PubMed ID: 35695616
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Dihydro-sphingosine 1-phosphate interacts with carrier proteins in a manner distinct from that of sphingosine 1-phosphate.
    Mishima Y, Kurano M, Kobayashi T, Nishikawa M, Ohkawa R, Tozuka M, Yatomi Y.
    Biosci Rep; 2018 Oct 31; 38(5):. PubMed ID: 30279204
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Impaired endothelial barrier function in apolipoprotein M-deficient mice is dependent on sphingosine-1-phosphate receptor 1.
    Christensen PM, Liu CH, Swendeman SL, Obinata H, Qvortrup K, Nielsen LB, Hla T, Di Lorenzo A, Christoffersen C.
    FASEB J; 2016 Jun 31; 30(6):2351-9. PubMed ID: 26956418
    [Abstract] [Full Text] [Related]

  • 33. High-density lipoprotein from end-stage renal disease patients exhibits superior cardioprotection and increase in sphingosine-1-phosphate.
    Brinck JW, Thomas A, Brulhart-Meynet MC, Lauer E, Frej C, Dahlbäck B, Stenvinkel P, James RW, Frias MA.
    Eur J Clin Invest; 2018 Feb 31; 48(2):. PubMed ID: 29178180
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Apolipoprotein M Inhibits Angiogenic and Inflammatory Response by Sphingosine 1-Phosphate on Retinal Pigment Epithelium Cells.
    Terao R, Honjo M, Aihara M.
    Int J Mol Sci; 2017 Dec 31; 19(1):. PubMed ID: 29301231
    [Abstract] [Full Text] [Related]

  • 38. Apolipoprotein M and Sphingosine-1-Phosphate Receptor 1 Promote the Transendothelial Transport of High-Density Lipoprotein.
    Velagapudi S, Rohrer L, Poti F, Feuerborn R, Perisa D, Wang D, Panteloglou G, Potapenko A, Yalcinkaya M, Hülsmeier AJ, Hesse B, Lukasz A, Liu M, Parks JS, Christoffersen C, Stoffel M, Simoni M, Nofer JR, von Eckardstein A.
    Arterioscler Thromb Vasc Biol; 2021 Oct 31; 41(10):e468-e479. PubMed ID: 34407633
    [Abstract] [Full Text] [Related]

  • 39. A Novel Perspective on the ApoM-S1P Axis, Highlighting the Metabolism of ApoM and Its Role in Liver Fibrosis and Neuroinflammation.
    Hajny S, Christoffersen C.
    Int J Mol Sci; 2017 Jul 27; 18(8):. PubMed ID: 28749426
    [Abstract] [Full Text] [Related]

  • 40. Apolipoprotein M induces inhibition of inflammatory responses via the S1PR1 and DHCR24 pathways.
    Wang M, Luo GH, Liu H, Zhang YP, Wang B, Di DM, Zhan XH, Yu Y, Yao S, Zhang XY, Xu N.
    Mol Med Rep; 2019 Feb 27; 19(2):1272-1283. PubMed ID: 30569161
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 52.